Adrenoleukodystrophy: Unusual clinical and radiographic manifestation

Southern Medical Journal

Volumn 91, Issue 8, 1998, Pages 770-774

  Williams, Geraldine A ^a,b   Pearl, Gary S ^a   Pollack, Michael A ^a   Anderson, Robert E ^a  

^a ORLANDO HEALTH   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GLIAL FIBRILLARY ACIDIC PROTEIN; VERY LONG CHAIN FATTY ACID;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; ARTICLE; BRAIN BIOPSY; CAPILLARY GAS CHROMATOGRAPHY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEMYELINATION; ELECTRON MICROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ULTRASTRUCTURE; WHITE MATTER;

EID: 0031878144     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199808000-00017     Document Type: Article

References (16)

1. Siemerling E, Creutzfeldt HG: Bronzkrankenheit und sklerorisende Encephalomyelitis (diffuse sclerosis). Arch Psychiatry Nervenkr 1923; 68:217-244
2. Lazo O, Contreras M, Bhushan A, et al: Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency. Arch Biochem Biaphys 1989; 270:722-728
3. Higgins CF: ABC transporters: from microorganism to man. Annu Rev Cell Biol 1992; 8:67-113
4. Schaumberg H, Powers JM, Raine CS, et al: Adrenoleukodystrophy: a clinical and pathological study of 17 cases. Arch Neural 1975; 33:577-591
5. Moser HW: Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997; 120:1485-1508
6. Moser HW, Bergin A, Naidu S, et al: Adrenoleukodystrophy: new aspects of adrenal cortical disease. Endocrinol Metab Clin North Am 1991; 20:297-318
7. Powers JM, Schaumberg HH: The adrenal cortex in adrenoleukodystrophy: Arch Pathol 1973; 96:305-310
8. Boles DJ, Craft DA, Padgett DA, et al: Clinical variation in X-linked adrenoleukodystrophy-fatty acid and lipid metabolism in cultured fibroblasts. Biochem Med Metab Biol 1991; 45:74-91
9. Moser HW, Moser AB, Powers JM, et al: Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology 1981; 31:1241
10. Battaglia A, Harden A, Pampiglione G, et al: Adrenoleukodystrophy: neurophysiological aspects. J Neurosurg Psychiatry 1981; 44:781
11. Dubois PJ, Freemark M, Lewis D, et al: Atypical findings in Adrenoleukodystrophy. J Comput Assist Tomogr 1981; 5:88
12. Moser HW, Power HM, Smith KD: Adrenoleukodystrophy: molecular genetics, pathology and Lorenzo's oil. Brain Pathol 1995; 5:259-266
13. Rizzo WB, Leshner RT, Odone A, et al: Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Neurology 1989; 39:1415-1422
14. Aubourg P, Blanche S, Jambaque I, et al: Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplatation. N Engl J Med 1990; 322:1860-1866
15. Krivit W, Shapiro E, Lockman L, et al: Recommendations for treatment of childhood cerebral form of adrenoleukodystrophy. Correction of Certain Genetic Diseases by Transplantation. Hobbs JR, Riches PG (eds). London, COGENT Trust, 1992, pp 38-49
16. Wilkinson IA, Hopkins IJ, Pollard AC: Can head injury influence the site of demyelination in adrenoleukodystrophy? Dev Med Child Neurol 1987; 29:797-800